Genome-Based Diagnostics Clarifying Pathways to Clinical Use: Workshop Summary (2012) / Chapter Skim
Currently Skimming:
Appendix B: Speaker Biographical Sketches
Appendix B: Speaker Biographical Sketches
Pages 69-76
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 69... ...
She is director of the University of Washington Center for Genomics and Healthcare Equality, a National Human Genome Research Institute Center of Excellence in Ethical, Legal, and Social Implications research, and codirector of the Northwest-Alaska Pharmacogenomic Research Network. Nicholas Conti, Ph.D., M.B.A., is Vice President, Business Development for Quest Diagnostics.
|
From page 70... ...
From 2001 to 2003 he was Divisional Vice President of Regulatory and Clinical Affairs, Quality Systems and Medical Reimbursement at Vysis (wholly owned by Abbott Laboratories) , a genomic disease management company.
|
From page 71... ...
He received his M.D. from the Indiana University School of Medicine in 1979, followed by a residency in internal medicine at the University of Texas Health Science Center at Dallas, Texas (hence renamed University of Texas Southwestern Medical Center at Dallas; Parkland Memorial and affiliated hospitals)
|
From page 72... ...
He has published abstracts, journal articles, and book chapters, as well as lectured extensively on the topics of pediatric health, quality of care, nurse practitioner education, and family dynamics. He is also professor emeritus at the University of Vermont and the Medical Director Clinical Policy Development for Humana, Inc., in Jackson, Wyoming.
|
From page 73... ...
Dr. Leonard is editor of two molecular pathology textbooks and has spoken widely on various molecular pathology test services, the future of molecular pathology, and the impact of gene patents on molecular pathology practice.
|
From page 74... ...
Under his direction, Ortho-Clinical Diagnostics became the first diagnostics company to gain FDA approval for hepatitis assay testing on random access automation for clinical laboratories. In 1995 he joined Sanofi Diagnostics Pasteur as Director of Clinical and Regulatory Affairs, and Worldwide Group Leader for cancer diagnostics.
|
From page 75... ...
Prior to co-founding Genomic Health in 2000, he served for 14 years in various roles in Discovery Research and Medical Affairs at Genentech, Inc., a biotechnology company dedicated to using human genetic information to discover, develop, manufacture, and commercialize medicines to treat patients with serious or life-threatening medical conditions. He led the clinical team that gained approval for Herceptin®, a targeted biologic treatment for breast cancer.
|
From page 76... ...
Tunis was the Chief Medical Officer at CMS, where he had lead responsibility for clinical policy for the Medicare and Medicaid programs. Previously he served as the Director of the Health Program at the Congressional Office of Technology Assessment and as a health policy advisor to the U.S.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.